Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.

NCT02001857 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Prostate or Bladder Cancer

Interventions

DRUG: 1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery.

Sponsor

University Hospital, Ghent

Collaborators

[object Object]